Evofem Biosciences Says Vaginal Contraceptive Gel Phexxi Approved In Nigeria

RTTNews | 834 days ago
Evofem Biosciences Says Vaginal Contraceptive Gel Phexxi Approved  In Nigeria

(RTTNews) - Evofem Biosciences, Inc. (EVFM) announced Thursday that its hormone-free contraceptive vaginal gel Phexxi has been approved by the Nigerian Regulatory Agency NAFDAC (National Agency for Food and Drug Administration and Control). This is the first regulatory approval outside the U.S.

The regulatory dossiers have also been submitted in Ghana, Ethiopia and Mexico. The product will be potentially marketed under the brand name Femidence.

Nigeria is the most populous country in Africa and the seventh largest country in the world, with 45 million women of reproductive age.

read more
Evofem Biosciences Names Albert Altro As Interim CFO

Evofem Biosciences Names Albert Altro As Interim CFO

Evofem Biosciences, Inc. (EVFM) announced Thursday the appointment of Albert Altro as Interim Chief Financial Officer of the Company. He replaces Jay File, who is leaving the Company to explore other opportunities.
RTTNews | 680 days ago
Evofem Inks Deal With Pharmacy Benefit Managers In The U.S. For Access To Phexxi

Evofem Inks Deal With Pharmacy Benefit Managers In The U.S. For Access To Phexxi

Evofem Biosciences, Inc. (EVFM) announced Tuesday it has reached an agreement with one of the nation's largest pharmacy benefit managers (PBMs) to ensure most women covered by this plan can fill their Phexxi prescriptions for pregnancy prevention, without restrictions such as prior authorization or step therapy. Phexxi is an on-demand method of birth control used to prevent pregnancy.
RTTNews | 934 days ago
Rate Cut Hopes Boost European Stock Markets

Rate Cut Hopes Boost European Stock Markets

Optimism over interest rate cuts had traders in a happy mood on Friday as the major European stock markets finished solidly to the upside, extending recent gains.
RTTNews | 8h 53min ago